Scott Brun, who headed AbbVie Ventures until last April, has taken on an R&D advisory role at pharmaceutical company Horizon Therapeutics.

US-listed pharmaceutical company Horizon Therapeutics has hired Scott Brun, former head of corporate venturing unit AbbVie Ventures, as an adviser to its research and development leadership team.

Brun joined pharmaceutical firm AbbVie as vice-president of pharmaceutical development in 2012 when it spun off from Abbott Laboratories, where he had been since 2002.

Brun took the reins at AbbVie Ventures in four years later while also being named AbbVie’s vice-president of scientific affairs, and made GCV’s 2018 Powerlist before departing…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Robert Lavine

Robert Lavine is special features editor for Global Venturing.